Skip to main content
. 2007 Oct 31;22(5):802–809. doi: 10.3346/jkms.2007.22.5.802

Fig. 1.

Fig. 1

The hematoxylin-eosin stain of the low- and high-power fields (magnitude, ×20, ×400) of neointimal hyperplasia and inflammatory cell infiltration in abciximab-coated stent (A, B), sirolimus-eluting stent (C, D), and paclitaxel-eluting stent (E, F).